Studies in thyroid tumors suggest that Metformin increases p AMPK, reduces mTOR phosphorylation, downregulates S6K1/S6 signaling, and inhibits cyclin D1 and c MYC via the mTOR pathway. This evidence concerns the gene RPS6KB1 and thyroid tumor.